$1.46
0[0.00%]
At close: May 10
$1.46
0[0.00%]
After Hours: 4:38PM EDT
Passage Bio
(NASDAQ:PASG)Latest News for Passage Bio Stock (NASDAQ:PASG)
Passage Bio Stock (NASDAQ: PASG)
Categories: All
Tuesday, March 05, 2024
Monday, March 04, 2024
Friday, January 26, 2024
Monday, January 22, 2024
Wednesday, January 17, 2024
Thursday, December 21, 2023
Wednesday, December 20, 2023
- Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic PrioritiesVandana Singh - Dec 20, 2023, 10:57AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Dec 20, 2023, 8:07AM
- Passage Bio Announced Initial Safety And Biomarker Data From Three Cohort 1 Patients In The Ongoing Global Phase 1/2 upliFT-D Trial Of PBFT02, An Adeno-associated Virus-delivery Gene Therapy For Frontotemporal Dementia With Granulin MutationsBenzinga Newsdesk - Dec 20, 2023, 7:05AM
Tuesday, November 14, 2023
Monday, November 13, 2023
Friday, November 03, 2023
Wednesday, October 04, 2023
Tuesday, October 03, 2023
Monday, October 02, 2023
Tuesday, September 26, 2023
Tuesday, August 22, 2023
Tuesday, August 08, 2023
Monday, August 07, 2023
- Passage Bio Announces Interim Data From First Eight Patients with GM1 Gangliosidosis In Imagine-1 Study, Safety Data Up To 28 Months Showed Dose 1 & 2 Of PBGM01 Were Well Tolerated, With Favorable Safety & Immunological ProfileBenzinga Newsdesk - Aug 7, 2023, 7:36AM
- Passage Bio Q2 EPS $(0.44) Beats $(0.48) Estimate, Passage Bio Q1 EPS $(0.63) Misses $(0.49) Estimate; Cash, Cash Equivalents And Marketable Securities Of $151.5M Expected To Fund Operations Into Q4 2025Benzinga Newsdesk - Aug 7, 2023, 7:20AM
Thursday, August 03, 2023
Tuesday, August 01, 2023
Thursday, July 20, 2023
- Passage Bio Said Will Decrease Operating Expenses Through Ongoing Cash Management Initiatives and by Reducing Workforce by About 26%Charles Gross - Jul 20, 2023, 7:10AM
- Passage Bio Said On July 19, Announced Organizational Redesign To Further Extend Its Cash Runway; Said Simona King To Resign As CFO, Kathleen Borthwick Named Interim CFOCharles Gross - Jul 20, 2023, 7:09AM
Friday, June 30, 2023
Thursday, June 15, 2023
Wednesday, June 14, 2023
Friday, May 12, 2023
Thursday, May 11, 2023
Monday, April 03, 2023
Monday, March 27, 2023
Friday, March 24, 2023
Monday, March 06, 2023
Friday, March 03, 2023
Friday, February 24, 2023
Thursday, December 15, 2022
Wednesday, December 14, 2022
- Passage Bio Stock Jumps After Gene Therapy Study In Lysosomal Storage DisorderVandana Singh - Dec 14, 2022, 12:13PM
- Passage Bio shares are trading higher after the company announced interim clinical data from the first six patients with GM1 gangliosidosis in the Imagine-1 study.Benzinga Newsdesk - Dec 14, 2022, 9:00AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Dec 14, 2022, 8:06AM
- Passage Bio Announces Interim Data From First Six Patients With GM1 Gangliosidosis In Imagine-1 Study Showing 'low and high dose of PBGM01 were well tolerated and had a favorable safety profile'Bill Haddad - Dec 14, 2022, 7:05AM